Newspatrolling.com News cum Content Syndication Portal Online

Breaking News

India aligns with shift in global guidelines for influenza vaccination, urgent need to prioritise preventives
Earning $8,600 a day, senior analyst points out that XRP contracts can achieve
‘Sky Roads’ trace Xizang’s journey from isolation to modernity
BB Kitty Enters Strategic Cooperation in Vietnam, Accelerating Southeast Asia Market Expansion
Cancer Can’t Wait: Best of ASCO 2025 Bengaluru Unites 500 Experts to Drive Awareness, Prevention, and Early Detection

Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

Naman Bansal June 19, 2025 PR

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17^th March, 2025 to 21^st March, 2025.

Related Articles

Check Also

Dr. Muhammed Nazeer appointed International Advisor, Royal College of Physicians and Surgeons, Glasgow

Thiruvananthapuram, Kerala, August 22, 2025: Dr. Muhammed Nazeer, Senior Consultant, Group Coordinator, Orthopedics and Trauma …